SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-010719
Filing Date
2023-07-05
Accepted
2023-07-05 16:05:07
Documents
1
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form4-07052023_040701.html 4  
1 form4-07052023_040701.xml 4 3335
  Complete submission text file 0001415889-23-010719.txt   4888
Mailing Address 5 CENTERPOINTE DRIVE SUITE 400 LAKE OSWEGO OR 97035
Business Address
DOTSON JERROLD DUANE (Reporting) CIK: 0001388853 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 231068745

Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations